Literature DB >> 10556210

Induction of donor-type chimerism and transplantation tolerance across major histocompatibility barriers in sublethally irradiated mice by Sca-1(+)Lin(-) bone marrow progenitor cells: synergism with non-alloreactive (host x donor)F(1) T cells.

E Bachar-Lustig1, H W Li, H Gur, R Krauthgamer, H Marcus, Y Reisner.   

Abstract

Induction of transplantation tolerance by means of bone marrow (BM) transplantation could become a reality if it was possible to achieve engraftment of hematopoietic stem cells under nonlethal preparatory cytoreduction of the recipient. To that end, BM facilitating cells, veto cells, or other tolerance-inducing cells, have been extensively studied. In the present study, we show that BM cells within the Sca-1(+)Lin(-) cell fraction, previously shown to be enriched for early hematopoietic progenitors, are capable of reducing specifically antidonor CTL-p frequency in vitro and in vivo, and of inducing split chimerism in sublethally 7-Gy-irradiated recipient mice across major histocompatibility complex barriers. The immune tolerance induced by the Sca-1(+)Lin(-) cells was also associated with specific tolerance toward donor-type skin grafts. The minimal number of cells required to overcome the host immunity remaining after 7 Gy total body irradiation is very large and, therefore, it may be very difficult to harvest sufficient cells for patients. This challenge was further addressed in our study by demonstrating that non-alloreactive (host x donor)F(1) T cells, previously shown to enhance T-cell-depleted BM allografts in lethally irradiated mice, synergize with Sca-1(+)Lin(-) cells in their capacity to overcome the major transplantation barrier presented by the sublethal mouse model.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556210

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  Peripheral blood stem cell mobilization: new regimens, new cells, where do we stand.

Authors:  Louis M Pelus
Journal:  Curr Opin Hematol       Date:  2008-07       Impact factor: 3.284

2.  The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT.

Authors:  N Or-Geva; Y Reisner
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

Review 3.  Haploidentical hematopoietic stem cell transplantation: state of art.

Authors:  Y Reisner; F Aversa; M F Martelli
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

Review 4.  T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells.

Authors:  R J O'Reilly; G Koehne; A N Hasan; E Doubrovina; S Prockop
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

5.  Osteogenic and adipogenic cell fractions isolated from postnatal mouse calvaria.

Authors:  Pieter Steenhuis; K M Carr; G J Pettway; M A Ignelzi
Journal:  Cells Tissues Organs       Date:  2008-12-17       Impact factor: 2.481

Review 6.  Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases.

Authors:  Franco Aversa; Massimo F Martelli
Journal:  Springer Semin Immunopathol       Date:  2004-09-11

7.  Hematopoietic stem cell transplantation across major genetic barriers.

Authors:  Yair Reisner
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 8.  Reconstructing immunity after allogeneic transplantation.

Authors:  Cynthia R Giver; Jian-Ming Li; Mohammad S Hossain; Sagar Lonial; Edmund K Waller
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 9.  Immune tolerance in recipients of combined haploidentical bone marrow and kidney transplantation.

Authors:  M Sykes
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.